Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment: A Randomized Controlled Trial

NCT06710639 is registered in ClinicalTrials.gov with University of Salamanca as lead sponsor.

NCT NCT06710639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment: A Randomized Controlled Trial
Lead sponsor
University of Salamanca
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
January 31, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cognitive impairment, clinical trials, cognitive training, colon cancer, everyday cognition, oncology